Back to search

Netherlands· NL-6407b60c26a9

Tenofovirdisoproxil DOC Generici 245 mg filmomhulde tabletten

A tenofovir disoproxil product containing tenofovirdisoproxilsuccinaat, registered in Netherlands by DOC Generici S.r.l.. The same ATC class is registered in 15 of our 19 countries.

ATC J05AF07

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedTenofovirdisoproxil DOC Generici 245 …ATCJ05AF07REGISTER NO.NL-6407b60c26a9PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Tenofovir disoproxil is registered in 15 of 19 countries.

Countries holding a registration under ATC J05AF07 (tenofovir disoproxil), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose

Tenofovir disoproxil · ATC J05AF07

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tenofovir disoproxil costs, country by country.

Normalised to the WHO defined daily dose (0.245 g), the median price runs from $0.24 in United States to $14.17 in Switzerland — a ×59 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Tenofovir disoproxil · price per daily dose (0.245 g)

USD · FX 28 Sept 2026

  • CH Switzerland$14.17
  • FR France$4.15
  • US United States$0.24 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
TENOFOVIRDISOPROXILSUCCINAAT
Manufacturer
DOC Generici S.r.l.
Country
Netherlands (NL)
ATC code
J05AF07
ATC class
Tenofovir disoproxil
Defined daily dose
0.245 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    117059

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

4 interactions on record for tenofovir disoproxil.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Tenofovir disoproxil · interactions on record

4 records

4 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f8177650-2430-47d7-8d9b-0c1f920489a7
GET /v1/drugs/f8177650-2430-47d7-8d9b-0c1f920489a7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h117059_smpc_en.pdf",
  "strength": null,
  "atc_label": "Tenofovir Disoproxil",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg117059",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "GLYCEROLTRIACETAAT (E 1518)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "INDIGOKARMIJN ALUMINIUMLAK (E 132)",
    "LACTOSE 0-WATER",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL, GEPREGELATINEERD",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "TENOFOVIRDISOPROXILSUCCINAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h117059_piluk.pdf",
  "authorised_at": "2016/04/28",
  "procedure_number": "NL/H/3437/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "117059",
  "additional_monitoring": "N"
}

See everything about tenofovir disoproxil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.